Dual Antiplatelet Therapy Can Be Discontinued at Three Months after Implantation of Zotarolimus-Eluting Stent in Patients with Coronary Artery Disease

Table 3

Incidences of sent thrombosis in the 3- and 12-month DAPT groups after implantation of the endeavor zotarolimus-eluting stent.

	3-month DAPT; (88 lesions)	12-month DAPT; (81 lesions)	𝑃-value
Stent thrombosis, 𝑛 (%)	0 (0)	1 (1.2)	NS
0–30 days, 𝑛 (%)	0 (0)	0 (0)	NS
31–365 days, 𝑛 (%)	0 (0)	1 (1.2)	NS

DAPT: dual antiplatelet therapy; NS: not significant.